Born into a family of ophthalmologists in Argentina, Dr. Tosi received his medical degree at the University of La Plata School of Medicine, became Chief resident in ophthalmology and completed a retina fellowship for two years at the University of Buenos Aires. After working in private practice for three years with his family, he then moved to the United States to pursue his dream of becoming a clinician-scientist.
In 2006, Dr. Tosi joined Dr. Stephen Tsang’s laboratory research team at Columbia University, and was involved in research on gene therapy and stem-cell therapies for retinal degeneration-associated diseases such as age-related macular degeneration and retinitis pigmentosa. During this period, he was trained in the diagnosis and treatment of inherited retinal diseases and electrophysiology. In 2009, he received the Dobli Srinivasan Award for the best clinical research paper during the annual Residents-Fellows Research Day.
Dr. Tosi then moved to Detroit where he did his ophthalmology residency at Kresge Eye Institute and completed a fellowship in vitreo-retinal surgery under the guidance of Dr. Gary Abrams, a legendary figure in the field of vitreoretinal surgery. His training included management of complex retinal detachment and diabetic tractional retinal detachment. He received multiple awards for his research.
Dr. Tosi eventually moved to Albuquerque where he became the Director of the Retina Service at the University of New Mexico Health Sciences Center. He created the first retinal dystrophy clinic at New Mexico providing state-of-the art testing, including gene testing. Dr. Tosi has been involved as principal investigator in many seminal retinal clinical research trials and has published extensively in peer-reviewed scientific journals.
Dr. Tosi is licensed to practice in New York and is a member of the American Academy of Ophthalmology and the American Society of Retina Specialists. Dr. Tosi specializes in medical and surgical management of retinal diseases, including diabetic retinopathy, macular degeneration, and retinal detachment.